An evaluation of mechanisms by which tolerance to organ-specific antigens is lost using a transgenic mouse model.
Patients with type I diabetes lose immunologic tolerance to beta cell Ag and produce anti-self (beta cell) antibodies. We have examined mechanisms by which this self tolerance is lost using transgenic mice in which islet cells express human CD4. These mice are immunologically tolerant to this human protein; the tolerance appears to be characterized by the presence of self reactive B cells and nonresponsive T cells. Autoantibodies can be induced by immunization with CD4 in CFA; this autoantibody response is accompanied by minor peri-islet inflammation but diabetes is not induced. Tolerance can also be broken by provision of an independent covalently linked T cell epitope. Although this mimic can lead to the appearance of an autoantibody response, the autoimmune response can not be maintained by the endogenous Ag. We have also demonstrated that an inflammatory lesion leading to death of the CD4-containing beta cells may not be sufficient to break tolerance. These results have implications for potential mechanisms relating to the appearance of autoantibodies in patients with type I diabetes.
Martin
L
L
Department of Endocrine Research, Genentech, Inc., South San Francisco, CA 94080.
Mora-Worms
M
M
Lucas
C
C
Reynolds
C
C
Stewart
T A
TA
D000818:Animals; D001324:Autoantigens / Q000276:immunology; D015704:CD4 Antigens / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D015870:Gene Expression; D006801:Humans; D007108:Immune Tolerance; D007371:Interferon-gamma / Q000235:genetics; D007515:Islets of Langerhans / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D008822:Mice, Transgenic; D011489:Protein Denaturation; D012333:RNA, Messenger / Q000235:genetics
D001324:Autoantigens; D015704:CD4 Antigens; D012333:RNA, Messenger; D007371:Interferon-gamma